Last updated: September 25, 2024
Sponsor: Clear Guide Medical
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
SCENERGY
Clinical Study ID
NCT04039490
CNMC Ph II Trial
Ages 1-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- any pediatric patient scheduled for a vessel cannulation at CNMC
Exclusion
Exclusion Criteria:
- none
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: SCENERGY
Phase:
Study Start date:
February 06, 2024
Estimated Completion Date:
August 31, 2025
Study Description
Connect with a study center
Children's National Medical Center
Washington, District of Columbia 20910
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.